@Tabyron169 Have a dig around through some of these threads....

@Tabyron169

Have a dig around through some of these threads. Plenty of well informed holders floating around here. But to briefly answer your question.

We have the funds through to DFS, expected Dec 17. In the process of delineating feed sources at 3 seperate deposits as we speak.

We recently ran a 198 hour continuous trial for an unnamed current producer (we have our theories), and achieved 99.9% LCE at a recovery of 90%. Can't beat that with a stick!

Following DFS, we will be requiring approx $35m for the the phase 1 plant providing an IRR of circa 60%, payback 18 months delivering a profit circa $25m p/a and scaling up to a full scale plant as revenue/partnerships allow.

Of note, we are also currently delineating a JORC compliant Spodumene resource at Lemare (Canada), which we theorise could be sold to one of our neighbours including Nemaska, Critical Elements, Galaxy and others. With those headliners all having economically viable resources but not the motherload of PLS or KDR proportions.

Therefore, for economies of scale and LOM efficiencies. We may get a solid price for Lemare from one of them, to fund the phase 1 plant eliminating or minimising payback and fast tracking expansion possibilities.

Looking at producing mid 2019. All is on track so far. Solid management that have done all this before and both our chairman and MD, have both separately been instrumental in building Billion dollar CO's.

There is a lot to like here. Have a dig around and don't be shy to ask questions. They're a friendly bunch in here.